To the Editor I write to report disclosures that I inadvertently omitted in my conflict of interest disclosure statement for the article, “Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women: A Randomized Clinical Trial,” published in JAMA Psychiatry on January 22, 2020.1 I had disclosed potential conflicts of interest/relevant financial activities for the 2 years prior to submission. In reviewing the disclosure requirements of the journal, I note that this was an error as the disclosure requirement covers a period of the prior 3 years. I would, as a result, like to add these relationships to the originally published disclosure statement: grants from Axsome Therapeutics and Reveal Biosensors and personal fees from Adare, Millennium Pharmaceuticals, Pernix, and Otsuka Pharmaceutical outside the submitted work. I appreciate this being brought to my attention and being provided the opportunity to correct this omission.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Krystal AD. Omitted Conflict of Interest Disclosures. JAMA Psychiatry. 2020;77(7):768. doi:10.1001/jamapsychiatry.2020.0616
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: